Ingrid Kohut, DO

Hematology, Medical Oncology
Accepting new patients
Sees patients age 18 and up
Penn Hematology/Oncology Pennsylvania Hospital
View 1 additional location
Make an appointmentCall 800-789-7366
Penn Medicine Provider

About me

  • Clinical Associate Professor of Medicine (Hematology-Oncology)

My education and training

  • Medical School: Philadelphia College of Osteopathic Medicine
  • Residency: Temple University Hospital
  • Residency: Drexel University
  • Fellowship: Drexel University

Reviews

Average Rating

912 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
she cares
Anonymous
April 2026
dr. kohut was thorough and provided helpful information. she is very kind.
Anonymous
April 2026
very professional and knowledgeable and caring
Anonymous
April 2026
dr kohut is an outstanding dr who has a great deal of knowledge

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Kohut is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

E.S. Kim, B. Halmos, I. F. Kohut, T. Patel, R.D. Rostorfer, A.I. Spira, A. Cseh, J. McKay, G.Wallenstein, K.F. Mileham. Results of the Afatinib Expanded Access Program (EAP): Safety and Efficacy. Poster #182 , Presented at the Chicago Multidisciplinary Symposium in Thoracic Oncology, October 30-November 1, 2014.: 2014

Warsame R. Kohut IE. Dispenzieri A. Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS. , European Journal of Haematology, 88(6): 2012,549-50